MYH9 and pulmonary fibrosis: Collectively, these data demonstrate the anti-fibrotic role of TP53TG1 in pulmonary fibrosis through inhibiting MYH9 protein expression, which might be attributed to decreased myofibroblasts differentiation and ECM deposition (Fig. 8).